Peripheral Arterial Disease (PAD) Treatment Devices

May 16, 2014 — In a move to expand significantly its portfolio of solutions for peripheral interventions, Boston Scientific Corp. has entered into a definitive agreement to acquire the interventional division of Bayer AG for $415 million...

The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD).

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

bard, DEB, drug eluting balloon

The first clinical trial in the United States to study the use of drug-coated ...

A new series of expert consensus recommendations developed by the Society for Cardiovascular Angiography and Interventions (SCAI) will help physicians...
July 18, 2014 — Avinger announced that John Pigott, M.D., of Jobst Vascular Institute, Toledo, Ohio, enrolled the first patient in the VISION trial, a global...
July 11, 2014 — Cordis Corp. announced the launch of its Saber PTA (percutaneous transluminal angioplasty) dilatation catheter for the treatment of patients...
FDA Recommendation Lutonix Drug Coated Balloon Catheter
C. R. Bard Inc. announced that the U.S. Food and Drug Administration’s (FDA) Circulatory System Devices Advisory Panel provided a unanimous favorable...
Cordis Corp.'s Saber PTA (percutaneous transluminal angioplasty) dilatation catheter is for the treatment of patients with peripheral
Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) are for the treatment of peripheral...
Boston Scientific's OffRoad Re-Entry Catheter System treats complete arterial blockages in the major arteries of the legs. ...
AtheroMed's Phoenix Atherectomy System. This system allows physicians to treat peripheral artery disease (PAD) with a low...

Articles

FDA Recommendation Lutonix Drug Coated Balloon Catheter
C. R. Bard Inc. announced that the U.S. Food and Drug Administration’s (FDA) Circulatory System Devices Advisory Panel provided a unanimous favorable...
New appropriate use expert consensus documents developed by the Society for Cardiovascular Angiography and Interventions (SCAI) provide guidance on treating...
Medtronic announced it is purchasing Covidien in a cash-and-stock deal for $42.9 billion. Once the transaction is completed, Medtronic will have significantly...
May 16, 2014 — In a move to expand significantly its portfolio of solutions for peripheral interventions, Boston Scientific Corp. has entered into a definitive...

Video Center

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
1 week 6 days ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
2 weeks 5 days ago
The key cardiology news coming out of the 2014 meeting for the Society of Nuclear Medicine and...
4 weeks 5 days ago
CVIS, cardiovascular information system, webinar
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle efficiency benefits of a modern cardiovascular...
The webinar "Implementing Robotic PCI — Why and How to Start a Successful Program" defines optimal strategies for launching a successful robotic percutaneous coronary intervention (PCI) program. The...
This webinar focuses on implementation of different strategies to help clinicians reduce radiation exposure during interventional cardiology procedures, both for patient and operators. It offers an...

Comparison Charts

Sorry there is no data available